Archive for October, 2007

Prostate News

• Vitamin C, E Supplements Won#39;t Help Prevent Cancer (HealthDay)
  HealthDay - SUNDAY, Nov. 16 (HealthDay News) -- Coming on the heels of two studies discounting the usefulness of vitamin B, folic acid, vitamin D and calcium supplements for cancer prevention, U.S. researchers report that vitamins C and E supplements won#39;t help prevent cancer, either.
• Diabetes drugs tied to lower prostate cancer risk (Reuters)
  Reuters - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report.
• Gene Screen Might Predict Prostate Cancer (HealthDay)
  HealthDay - MONDAY, Nov. 17 (HealthDay News) -- Doctors may someday be able to use five genetic markers to assess whether a man is at high risk to develop prostate cancer, a new study suggests.
• Aspirin may mask prostate cancer, study hints (Reuters)
  Reuters - Middle-aged men who take aspirin or other quot;nonsteroidal anti-inflammatory drugquot; (NSAID) have significantly lower levels of a blood protein used to spot prostate cancer than men who don#39;t take these widely used drugs, a study shows.
• Embryo preservation often works for cancer patients (Reuters)
  Reuters - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate.
• Agent Orange exposure linked to prostate cancer (Reuters)
  Reuters - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features.
• Statins Lower Blood Marker for Prostate Cancer (HealthDay)
  HealthDay - THURSDAY, Oct. 30 (HealthDay News) -- A new study shows that men who take cholesterol-lowering drugs called statins have lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk.
• Major Study of Supplements and Prostate Cancer Halted (American Cancer Society)
  American Cancer Society - The National Cancer Institute has stopped a major clinical trial studying whether vitamin E and selenium can prevent prostate cancer because early analysis suggests the supplements don't work. What's more, there is some evidence that they may actually be harmful.
• Statins cut key indicator of prostate cancer: study (Reuters)
  Reuters - Cholesterol-lowering drugs called statins modestly reduce levels of a protein in a man#39;s blood that doctors often use to screen for prostate cancer, researchers said on Tuesday.
• NCI: No prostate benefit from vitamin E, selenium (AP)
  AP - The government is stopping part of a major study of whether vitamin E and selenium prevent prostate cancer #151; because the supplements aren't working and there's a hint of risk.